4Wiegand UK,LeJeune D,Boguschewski F,et al.Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery:influence of patient morbidity,operation strategy,and perioperative antiplatelet/anticoagulation therapy[J].Chest,2004,126(4):1 177.
5Klinkhardt U,Kirchmaier CM,Westrup D,et al.Ex vivo-in vitro interaction between aspirin,clopidogrel,and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A[J].Clin Pharmacol Ther,2000,67:305.
6Harder S,Klinkhardt U,Alvarez JM.Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy:pharmacokinetic and pharmacodynamic considerations[J].Clin Pharmacokinet,2004,43(14):963.
7Weber AA,Braun M,Hohlfeld T,et al.Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers[J].Br J Clin Pharmacol,2001,52(3):333.
8Jaffer AK,Ahmed M,Brotman DJ,et al.Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy:a standardized bridging therapy protocol[J].J Thromb Thrombolysis,2005,20(1):11.
9Larson BJ,Zumberg MS,Kitchens CS.A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk[J].Chest,2005,127(3):922.
